Allergy & Anaphylaxis Australia
Mimi Tang is an esteemed director at the Murdoch Children's Research Institute, specializing in allergy translation and allergy immunology, with a longstanding commitment to developing future clinicians and researchers. As Interim CEO and Chief Scientific Officer at Prota Therapeutics Pty Ltd since 2017, Mimi has pioneered a probiotic immunotherapy platform for food allergies, drawing on over 25 years of experience treating children with allergic disorders. Additionally, Mimi serves as a Consultant Immunologist Allergist and inaugural Director of the Department of Allergy and Immunology at The Royal Children's Hospital, where a merger led to their leadership role in 2006. With a professorial position at the University of Melbourne and various board memberships in prominent allergy and immunology organizations, Mimi's extensive educational background includes a PhD in Immunology and multiple fellowships in Allergy and Immunology, Paediatrics, and Immunopathology.
This person is not in the org chart
This person is not in any teams
Allergy & Anaphylaxis Australia
Allergy & Anaphylaxis Australia (“A&AA”) is a registered charity and Australia’s only national support organisation, dedicated to helping individuals and carers alike in managing allergy and anaphylaxis. We strive to raise awareness of allergic conditions including life threatening allergies in the community by providing evidence based information, resources and services to support children and adults living with allergic disease. Allergic disease is a chronic condition that includes allergic rhinitis (hayfever), atopic dermatitis, allergic asthma, food and insect allergies and other potentially life-threatening conditions. We help Australians manage the everyday, improving quality of life, health and wellbeing. As food allergy is a community issue, A&AA's outreach and education is broad. The circle of care embraces and engages individuals at risk of anaphylaxis and those who care for them. We also work closely with related areas in state and commonwealth government departments, food industry, health and teaching professionals, as well as the Australian community at large. The organisation has a small workforce and receives invaluable support from a core group of dedicated volunteers. A&AA is governed by constitution and a Board. We utilise the expertise of a Medical Advisory Board as required. We are a part of an international alliance of like-minded organisations and work closely with peak medical bodies including the Australasian Society of Clinical Immunology and Allergy (ASCIA). The National Allergy Strategy (“NAS”) is a partnership between ASCIA and A&AA, of which our CEO is the co-chair.